Your browser doesn't support javascript.
loading
DEF6 deficiency, a mendelian susceptibility to EBV infection, lymphoma, and autoimmunity.
Fournier, Benjamin; Tusseau, Maud; Villard, Marine; Malcus, Christophe; Chopin, Emilie; Martin, Emmanuel; Jorge Cordeiro, Debora; Fabien, Nicole; Fusaro, Mathieu; Gauthier, Alexandra; Garnier, Nathalie; Goncalves, David; Lounis, Sonia; Lenoir, Christelle; Mathieu, Anne-Laure; Moreews, Marion; Perret, Magali; Picard, Capucine; Picard, Cécile; Poitevin, Françoise; Viel, Sébastien; Bertrand, Yves; Walzer, Thierry; Belot, Alexandre; Latour, Sylvain.
Affiliation
  • Fournier B; Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, Institut National de la Santé et de la Recherche Médicale (Inserm) UMR 1163, F-75015, Paris, France; Université de Paris, Imagine Institute, F-75015, Paris, France.
  • Tusseau M; International Center for Infectiology Research, Inserm U1111, Ecole Normale Supérieure de Lyon, Université Lyon 1, CNRS, UMR5308, Lyon, France.
  • Villard M; Immunology Department, Centre Hospitalier Lyon Sud, Pierre-Bénite, Lyon 1 University, France.
  • Malcus C; Immunology Laboratory, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France.
  • Chopin E; Centre de Biotechnologie Cellulaire, Centre de Biologie et Pathologie Est, Hospices Civils de Lyon, Bron, France.
  • Martin E; Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, Institut National de la Santé et de la Recherche Médicale (Inserm) UMR 1163, F-75015, Paris, France; Université de Paris, Imagine Institute, F-75015, Paris, France.
  • Jorge Cordeiro D; Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, Institut National de la Santé et de la Recherche Médicale (Inserm) UMR 1163, F-75015, Paris, France; Université de Paris, Imagine Institute, F-75015, Paris, France.
  • Fabien N; Immunology Department, Centre Hospitalier Lyon Sud, Pierre-Bénite, Lyon 1 University, France.
  • Fusaro M; Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, Institut National de la Santé et de la Recherche Médicale (Inserm) UMR 1163, F-75015, Paris, France; Study Center for Primary Immunodeficiencies, Assistance Publique Hôpitaux de Paris, Necker-Enfants Malades Hospital, F-75015,
  • Gauthier A; Institut d'Hématologie et d'Oncologie Pédiatrique, Hospices Civils de Lyon, Lyon, France.
  • Garnier N; Institut d'Hématologie et d'Oncologie Pédiatrique, Hospices Civils de Lyon, Lyon, France.
  • Goncalves D; Immunology Department, Centre Hospitalier Lyon Sud, Pierre-Bénite, Lyon 1 University, France.
  • Lounis S; Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, Institut National de la Santé et de la Recherche Médicale (Inserm) UMR 1163, F-75015, Paris, France; Université de Paris, Imagine Institute, F-75015, Paris, France.
  • Lenoir C; Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, Institut National de la Santé et de la Recherche Médicale (Inserm) UMR 1163, F-75015, Paris, France; Université de Paris, Imagine Institute, F-75015, Paris, France.
  • Mathieu AL; International Center for Infectiology Research, Inserm U1111, Ecole Normale Supérieure de Lyon, Université Lyon 1, CNRS, UMR5308, Lyon, France.
  • Moreews M; International Center for Infectiology Research, Inserm U1111, Ecole Normale Supérieure de Lyon, Université Lyon 1, CNRS, UMR5308, Lyon, France.
  • Perret M; Immunology Department, Centre Hospitalier Lyon Sud, Pierre-Bénite, Lyon 1 University, France.
  • Picard C; Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, Institut National de la Santé et de la Recherche Médicale (Inserm) UMR 1163, F-75015, Paris, France; Université de Paris, Imagine Institute, F-75015, Paris, France; Study Center for Primary Immunodeficiencies, Assistance Publiq
  • Picard C; Institut de Pathologie Multisite, Groupement Hospitalier Est, Hospices Civils de Lyon, UCBL Lyon 1 University, Lyon, France.
  • Poitevin F; Immunology Laboratory, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France.
  • Viel S; International Center for Infectiology Research, Inserm U1111, Ecole Normale Supérieure de Lyon, Université Lyon 1, CNRS, UMR5308, Lyon, France; Immunology Department, Centre Hospitalier Lyon Sud, Pierre-Bénite, Lyon 1 University, France.
  • Bertrand Y; International Center for Infectiology Research, Inserm U1111, Ecole Normale Supérieure de Lyon, Université Lyon 1, CNRS, UMR5308, Lyon, France; Institut d'Hématologie et d'Oncologie Pédiatrique, Hospices Civils de Lyon, Lyon, France.
  • Walzer T; International Center for Infectiology Research, Inserm U1111, Ecole Normale Supérieure de Lyon, Université Lyon 1, CNRS, UMR5308, Lyon, France.
  • Belot A; International Center for Infectiology Research, Inserm U1111, Ecole Normale Supérieure de Lyon, Université Lyon 1, CNRS, UMR5308, Lyon, France; National Referee Centre for Rheumatic and AutoImmune and Systemic diseases in childrEn (RAISE), France; Pediatric Nephrology, Rheumatology, Dermatology Unit
  • Latour S; Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, Institut National de la Santé et de la Recherche Médicale (Inserm) UMR 1163, F-75015, Paris, France; Université de Paris, Imagine Institute, F-75015, Paris, France. Electronic address: sylvain.latour@inserm.fr.
J Allergy Clin Immunol ; 147(2): 740-743.e9, 2021 02.
Article in En | MEDLINE | ID: mdl-32562707

Full text: 1 Database: MEDLINE Main subject: Autoimmune Diseases / Epstein-Barr Virus Infections / Guanine Nucleotide Exchange Factors / DNA-Binding Proteins / Lymphoma Limits: Adolescent / Child / Female / Humans / Infant / Male Language: En Journal: J Allergy Clin Immunol Year: 2021 Type: Article Affiliation country: France

Full text: 1 Database: MEDLINE Main subject: Autoimmune Diseases / Epstein-Barr Virus Infections / Guanine Nucleotide Exchange Factors / DNA-Binding Proteins / Lymphoma Limits: Adolescent / Child / Female / Humans / Infant / Male Language: En Journal: J Allergy Clin Immunol Year: 2021 Type: Article Affiliation country: France